The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $268 million Indefinite Delivery Contract to Camris International, LLC, a for-profit organization, for professional, scientific, and technical support services. The contract, which has a potential value of $545 million, allows NIAID to rapidly acquire a wide range of services to support its biomedical research initiatives, including efforts related to infectious diseases, vaccine development, clinical trials, and emerging public health threats like COVID-19. Camris International also holds other significant Indefinite Delivery Vehicles with NIAID and the Defense Health Agency, positioning the company as a key partner in advancing critical research and development across federal agencies.
Under this contract, Camris International has been awarded numerous task orders to provide professional, scientific, and technical support services to NIAID's various divisions, such as the Vaccine Research Center, Division of AIDS, Division of Microbiology and Infectious Diseases, and Division of Intramural Research. The task orders, which range in value from $88,915.68 to $1,052,195.38, do not have any set-aside designations, indicating they were awarded through full and open competition. The services delivered under these task orders support a wide variety of NIAID's biomedical research programs, including COVID-19 vaccine and countermeasure development, public health emergency preparedness, and other critical initiatives aimed at addressing infectious diseases and improving public health.